Background. The epithelial Ca 2q channel (ECaC) exhibits the defining properties for being the gatekeeper in 1,25-dihydroxyvitamin D 3 -regulated Ca 2q (re)absorption. Its recently cloned human orthologue (ECaC1) could, therefore, represent a crucial molecule in human disorders related to Ca 2q -wasting such as idiopathic hypercalciuria (IH). Methods. Fifty-seven members of nine families with IH were investigated. Phenotyping was performed by measurements of urinary Ca 2q excretion, while other underlying disorders were appropriately excluded. Initially, the recently suggested locus for kidney stoneassociated hypercalciuria on chromosome 1q23.3-q24 was investigated. Next, direct mutation analysis of all 15 exons of the ECAC1 gene and 2.9 kb upstream from the start codon was performed. hECaC1, heterologously expressed in human embryonic kidney 293 cells, was characterized by patch-clamp analysis.
Introduction
Because of the various important functions of Ca 2q , disturbances of its homeostasis can result in a broad range of abnormalities. Among such disorders, idiopathic hypercalciuria (IH), defined as increased urinary excretion of Ca 2q in the absence of any known underlying cause, is frequently observed. Because of the high prevalence and the close correlation to Ca 2q -related stone formation, its socio-economic impact is considerable [1] . In many cases, the family history is positive and it has been suggested that in these patients, the disease is primarily inherited as an autosomal dominant trait [2] . Intensive investigations have been performed in the past to elucidate responsible mechanisms and several potential candidate genes for IH have been excluded [3] [4] [5] . In IH patients, research has centred on the uptake and excretion of Ca 2q , as intestinal hyperabsorption of Ca 2q could lead, via increased plasma Ca 2q levels, to an increased filtered load of Ca 2q surpassing the renal reabsorption capacity. Likewise, a primary defect of renal Ca 2q reabsorption could lead directly to hypercalciuria [6] . It is also noteworthy that some studies have demonstrated decreased bone density in patients with IH [7] . Additionally, a well-characterized rat model of hypercalciuria shows simultaneous alterations in Ca 2q handling in kidney, intestine, and bone [8] . Recently, Reed and co-workers [9, 10] identified an area on chromosome 1 linked to the transmission of hypercalciuria, while another group reported suggestive evidence of a gene locus on chromosome 12 in close vicinity to the vitamin D receptor (VDR) gene. The VDR gene product itself has been extensively investigated for its involvement in Ca 2q -related dieases, but with inconsistent results [11] . There is considerable evidence that patients suffering from hypercalciuria might not represent a homogenous group. Moreover, theories on the pathogenesis of IH were not substantiated by identification of mutations in candidate genes expressed in kidney, intestine, bone, or other tissues.
Recently, the apical Ca 2q entry step facilitating transcellular Ca 2q transport in kidney and small intestine was identified [12] . This long-sought molecule, named epithelial calcium channel or ECaC1, is localized in the apical membrane of 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 )-responsive epithelia where it functions as a high Ca 2q selective channel. Thus, ECaC1 possesses the defining properties of the 'guardian' of transcellular Ca 2q transport and might play a crucial role in Ca 2q -related disorders [13, 14] . Subsequently, its human orthologue was cloned and its genomic localization and organization was elucidated to provide the basis for functional and mutational analyses [15, 16] .
In the present study, the ECaC1 coding sequence and its 59-flanking region were screened for muations in nine families with IH. This was followed by patchclamp analysis, thereby providing an in-depth electrophysiological characterization of the human epithelial Ca 2q channel.
Subjects and methods

Pedigrees and phenotyping
Included were nine families (five spanning two generations and four spanning three generations) with a total of 57 members (29 females and 28 males). The median age of all members was 16.2 years with a range from 3.1 to 65.2 years. According to generally accepted reference values, family members with a urinary Ca 2q excretion of )0.1 mmolukg body weightu24 h were considered as being hypercalciuric [1] . Associated symptoms included abdominal colics, haematuria, urinary tract infections, and recurrent kidney stones, the latter revealed by history, abdominal X-ray, anduor ultrasound. Although kidney stones were age-dependent and inconsistent in their appearance, they were only encountered in hypercalciuric, but never in normocalciuric family members. 
Biochemical analysis
Haplotype analysis
Samples of peripheral blood were taken from all available family members and genomic DNA was isolated by means of standard procedures using a commercial DNA isolation system (Promega, Madison, WI, USA). Before investigating the ECAC1 gene, haplotype analysis was performed for two loci described in the literature (1q23.3-q24 and 12q12-14) by using the microsatellite markers D1S318 (GenBank TM Accession no. L14301), D1S196 (GenBank TM Accession no. Z16503), and D12S339 (GenBank TM Accession no. Z24131) [9, 10] . Semi-automated genotyping was performed on an ABI 377 DNA Sequencer and data were analysed by Genescan 2.1 and Genotyper 2.0 software (Perkin-Elmer Applied Biosystems, Foster City, CA, USA).
Screening the hECAC1 gene
DNA of 18 members of nine families (one affected and one non-affected per family) was subjected to direct mutation analysis. Oligonucleotides were selected based on the genomic sequence of hECAC1 as elucidated recently [15, 16] . Because of the short intron sequence between the exons 2 and 3, 5 and 6, 9 and 10 as well as 11 and 12, they were amplified by polymerase chain reaction (PCR) and sequenced as a single fragment. For the analysis of the coding sequence, all primers were located in non-coding (intronic) regions so that the intron-exon boundaries were amplified as well. PCR purification of the products and semi-automated sequencing was performed by standard procedures. The 59 flanking region of ECAC1 was amplified by the forward primer 59-GAGGACGAGGTAGGCAGAGAAGGGCAAGTG-39 and reverse primer 59-AAGTTTCTGGAGTTGGCTCCCG-GGCCCT-39 using a long range PCR (TAKARA, Shiga, Japan). The obtained 3 kb fragment was purified and subjected to direct sequencing using primers covering this fragment at position À2927, À2320, À1827, À1325, À817, and À447.
Construction of the hECaC1 transfection vector
The open reading frame of ECaC1 was amplified by reverse transcription (RT)-PCR using human kidney cortex RNA as described previously [15] . The forward and reverse primers were located at both ends of the open reading frame (forward 59-ATGGGGGGTTTTCTACCTAAG-39 and reverse 59-TCAAAAATGGTAGACCTCCTCTCC-39, GenBank TM Accession no. AJ271207.2). The obtained 2.3 kb product was subcloned into the pGEM T-Easy vector (Promega, Madison, WI, USA) and then cloned into the pCINeouIRESuGFP vector [17] . The sequence identity of the hECaC1 open reading frame was confirmed by sequence analysis.
Cell culture, transfection, and electrophysiology
Human embryonic kidney cells (HEK293) were grown in DMEM containing 10% (vuv) human serum, 2 mM L-glutamine, 2 Uuml penicillin, and 2 mguml streptomycin at 378C in a humidity controlled incubator with 10% CO 2 . HEK293 cells were transiently transfected with the pCINeou IRESuECaC1uGFP vector as described [17] . Cells were visually identified by their green appearance in the patchclamp set-up. Electrophysiological methods and Ca 2q measurements have been described in detail previously [17] . The standard extracellular solution ('Krebs') contained (in mM) 150 NaCl, 1 MgCl 2 , 10 HEPES, and 10 glucose, pH 7.4, adjusted with CsOH. To test the permeability of several monovalent cations, NaCl was replaced by an equimolar amount of KCl, LiCl, CsCl or N-methyl-Dglucosamine chloride (NMDG-Cl). 
Results
Phenotyping and biochemical analysis
Out of the nine families, one was of Spanish, two of Hungarian, one of Danish, and five of German origin. Fourteen out of the 28 male persons and 19 out of the 29 female persons were affected by hypercalciuria (Figure 1) . The difference in urinary Ca 2q excretion between the affected and non-affected family members was significant (P-0.001). All other parameters measured in serum and urine were not significantly different between the affected and the non-affected members (Table 1) . In all families, the pattern of transmission was consistent with a high-penetrance autosomal dominant mode of inheritance. Of note, it cannot be excluded that IH is a polygenic disease.
Exclusion of chromosomes 1 and 12
Analysis for the markers on chromosome 1 (D1S318 and D1S196) was performed by haplotype analysis, which did not identify a common haplotype segregating the affected families. This result is consistent with the formal exclusion of the above mentioned locus on chromosome 1 (Figure 1 ). For the region on chromosome 12, a major chromosomal discrepancy was encountered when a GenBank TM search for the marker D12S339 was performed. A full match was only obtained to a Human Genome Project working draft sequence on chromosome 3 (GenBank TM Accession no. NT_022490.2). However, the same marker was assigned to chromosome 12 according to the Marshfield map, the GB4 TM map, and the Généthon map. These findings suggest that this particular marker is not representative for the VDR locus, which has been unequivocally assigned to chromosome 12.
Mutation analysis of hECAC1
The coding sequences of hECAC1 obtained from the affected and non-affected family members did not differ from each other and were identical to the sequence deposited in the corresponding GenBank TM entry revealed by the Human Genome Project (NT_023640.5). Furthermore, intron-exon boundaries were also without differences between individuals. The presence of heterozygous variations in the coding sequence of ECaC1 were also excluded which was of special interest, as the disease is transmitted as an autosomal dominant trait. Thus, a mutation in the open reading frame of ECaC1 was excluded as being the underlying cause of the disease in these patients.
Subsequently, the 59-flanking region (39 kb) of the hECAC1 gene was investigated in all family members. Three single heterozygous nucleotide changes were found at position À2806 (GuC), À1600 (GuC), and À614 (GuA). This variation in the 59-flanking region did not correlate with the affection status. At positions À1674 to À1617, a TACA repeat was identified. The length of the repeat varied from (TACA) 11 to (TACA) 13 in the studied individuals, but was independent of the affection states. This TACA repeat, as well as the GuC polymorphism at position À1600, were located in close vicinity to an identified transcription activation consensus site, named activating protein-1 or AP-1. The GuA polymorphism at position À614 was located upstream of a putative vitamin D response element (VDRE) site as reported earlier (Figure 2 ) [13] .
Electrophysiological characteristics of hECaC1
Sequencing revealed that the pore region of hECaC1 contains four unique amino acids that are different in all other studied species [12, 15] . Therefore, the electrophysiological properties of hECaC1 heterologously expressed in HEK293 cells were measured. As shown in Figure 3A and B, large currents could be measured with high intracellular Ca 2q buffering in extracellular divalent free conditions, which were largely blocked by 1 mM Mg 2q . In the presence of extracellular Ca 2q , currents showed a highly positive reversal potential and currents in response to a negative Figure 4A and B) . As Ca 2q -dependent inactivation was most pronounced at negative potentials, current densities were measured at 0 mV as shown in Figure 4 . In this way, a sequence of channel conductance for bivalent cations of Ca 
Discussion
In the present study, mutations in the hECAC1 gene, consisting of 15 exons and 3 kb of the 59-flanking region, were not identified in nine families with IH. This finding does, therefore, not support a primary role for hECaC1 in the pathogenesis of IH in the studied families, but ECaC1 cannot be excluded as a candidate gene in other families with IH as the pathogenesis of the disease is heterogenous. Before the ECAC1 gene was investigated in our families, two loci recently suggested to play a role in Ca 2q stone-associated hypercalciuria were evaluated [9, 10] . A trait associated with intestinal Ca Notice the different scaling between the panels. Cells were loaded with 10 mM BAPTA through the pipette solution. (E) Current traces in response to a ramp protocol from À100 to q100 mV (duration is 400 ms, V H sq20 mV) in the presence of various concentrations of Ca 2q and Mg 2q , as indicated. Data are given as mean, median, and range. Number of individuals (n) included in the analysis of the different parameters is indicated between parentheses. Statistical analysis was performed using the Mann-Whitney U-test (n.s., not significant).
hyperabsorption in a severe form of absorptive hypercalciuria has been mapped to chromosome 1q23.3-q24 [9] . The markers used were sufficient to reveal a twopoint LOD score of 3.3 and analysis of the family members mapped the affected gene to a 4.3 Mb region between markers D1S2681 and D1S2815. In the present study, however, this locus on chromosome 1 could not be associated with IH by haplotype analysis using markers located within the designated region. In addition, the VDR locus on chromosome 12q12-q14 was implicated in a cohort of large French Canadian pedigrees with IH using four markers spanning a region of 11.2 cM [10] . However, the discriminating marker D12S339 has been assigned simultaneously to chromosomes 3 and 12. The VDR locus has, therefore, not been included as candidate gene in the present study.
It is generally known that IH, even the autosomal dominant form, is genetically heterogeneous. This is further substantiated by the present impossibility to confirm the assignment of a previously identified locus on chromosome 1. Because of the existing heterogeneity within subgroups of IH patients, direct mutation analysis was performed on the ECAC1 gene. The coding region of the ECAC1 gene did not contain mutations in the affected family members. Screening was then extended by analysing the nucleotide sequence 3 kb upstream of exon 1. This was of interest as there is increasing evidence that diseases are not only caused by mutations in the open reading frame of a gene, but also by variations of the respective promoter area. For instance, variations in the promoter influence the function of ion channels in Drosophila [18] . In addition, it was shown that a mutation in the coding sequence of human cystic fibrosis transmembrane regulator (CFTR) resulted in a different phenotype if associated with a naturally occurring allelic variation in the promoter [19] . Interestingly, the 59-flanking area of human ECAC1 contains several consensus sites for the binding of transcription factors including four VDREs. Accordingly, it was demonstrated that 1,25(OH) 2 D 3 regulates the expression of ECAC1 in the kidney on the transcriptional level [13] . There were, however, no mutations observed in this promoter region. We encountered a TACA repeat, which showed variation in length among the family members. This repeat is located 55 bp upstream of an AP-1 and cAMP response element consensus site (TGACGTCA) and might interfere with binding of the corresponding transcription factor. As functional data on the 59-flanking region of ECAC1 are lacking so far, it might be possible that other, yet unknown, sequences upstream or downstream of the ECAC1 gene influence transcriptional activity and might represent a putative target for future mutational analysis.
The otherwise conserved pore-forming region of hECaC1 contains four unique amino acids (T532, V540, A543, D548) which are not present in the sequence of other species [12, 15] . The critical role of the single pore residue, D542, for proper Ca 2q gating in rabbit ECaC1 was recently demonstrated [20] . It was, therefore, of importance to address the functional characteristics of the non-conserved pore region of hECaC1. Patch-clamp analysis demonstrated that hECaC1 exhibits the distinctive properties for being the prime molecule in transcellular Ca 2q (re)absorption. ECaC1 is constitutively activated, displays inward rectifying currents at negative membrane potentials, and exhibits a high Ca 2q selective permeability. The channel has also Ca 2q -dependent autoregulatory mechanisms, including fast inactivation and inhibition by elevated intracellular Ca 2q concentrations. With special regard to the unique amino acids in the poreforming region of hECaC1, the electrophysiological characteristics appeared to be similar to those of rabbit ECaC1 [20] . This suggests that the four variant amino acids are not critical for Ca 2q gating, at least not in the experimental set-up used in this study. The question why this variation only occurs in human ECAC1 whereas the other transcripts of the ECAC family are fully conserved in this area, even across the borders of species, remains unexplained.
In summary, we could not implicate the ECaC1 gene in IH in nine affected families. Because of the heterogeneity of the disease, however, the involvement of ECaC1 in other subtypes of IH cannot be excluded and needs further investigation.
